Cadazolid
- Generic Name
- Cadazolid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C29H29F2N3O8
- CAS Number
- 1025097-10-2
- Unique Ingredient Identifier
- 2OEA2UN10Y
- Background
Cadazolid has been used in trials studying the treatment of Clostridium Difficile Infection.
- Associated Conditions
- -
- Associated Therapies
- -
An MKK4 Inhibitor that Leverages the Body’s Natural Liver Regeneration Ability for Chronic Liver Disease
CDI, a leading cause of healthcare-associated diarrhea, requires novel antibiotics. Cadazolid, a hybrid antibiotic, shows potent in vitro activity against relevant C. difficile strains, avoids native gut flora, and is gut-restricted with minimal systemic circulation.
A Structurally Distinct MTA-Cooperative PRMT5 Inhibitor With a “Fantastic Fluorine Atom”
Cadazolid, a hybrid antibiotic, shows potent in vitro activity against hypervirulent and resistant Clostridioides difficile strains, while sparing native gut flora, designed for gut-restricted use.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath